(19)
(11) EP 1 068 193 A1

(12)

(43) Date of publication:
17.01.2001 Bulletin 2001/03

(21) Application number: 99909657.1

(22) Date of filing: 26.02.1999
(51) International Patent Classification (IPC)7C07D 401/06, A61K 31/445, C07D 295/14, A61K 31/495, C07D 209/08, C07D 215/08, C07D 265/36, A61K 31/535, C07D 279/16, A61K 31/54, C07D 209/54
(86) International application number:
PCT/US9904/309
(87) International publication number:
WO 9943/670 (02.09.1999 Gazette 1999/35)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 26.02.1998 US 30987

(71) Applicant: NEUROGEN CORPORATION
Branford, CT 06405 (US)

(72) Inventors:
  • KOVER, Renata, X.
    22470-220 Rio de Janeiro, RJ (BR)
  • TERDJANIAN, Silva
    New Britain, CT 06053 (US)
  • TRAN, Jennifer
    Guilford, CT 06437 (US)
  • THURKAUF, Andrew
    Danbury, CT 06811 (US)

(74) Representative: Eyles, Christopher Thomas et al
W.P. THOMPSON & CO.Celcon House289-293 High Holborn
London WC1V 7HU
London WC1V 7HU (GB)

   


(54) BENZYLPIPERAZINYL- AND BENZYLPIPERIDINYL ETHANONE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS DOPAMINE D 4? RECEPTOR ANTAGONISTS